Cardiovascular, renal, and metabolic (CVRM) diseases, including obesity and type 2 diabetes, are a major public health emergency, impacting over half of the global population, causing 19 million deaths annually, and imposing a tremendous burden on healthcare systems and society. Roche is uniquely positioned to address these challenges with its comprehensive pipeline of potential best- and first-in-class investigational medicines. The Roche Clinical Development organization is structured by therapeutic area and is responsible for developing and executing the late-stage development (Phase 2-3) clinical strategies and plans to deliver medically differentiated therapies that provide meaningful improvement to patients. We are seeking an accomplished and seasoned leader to drive our portfolio growth. This role requires a unique combination of scientific, business and therapeutic expertise with a proven track record of advancing R&D programs. The CVRM Therapeutic Area (TA) Strategic Business Lead is a newly established position reporting directly to the PDC CVRM TA Head. As a member of the TA Core Leadership Team (LT), you will drive, own, and be accountable for the strategic and operational alignment across key leadership groups within the Roche/Genentech R&D and commercialization ecosystem (for internal audience: including PDC, GPS, PDMA, gRED, and pRED) to support all relevant portfolio business needs. You will focus on building, maintaining, and continuously improving the TA by driving business acumen, operational excellence and fostering community across global sites.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees